Skip to content

Xencor XNCR Operating Cash Flow

Operating Cash Flow at other companies

Amgen logo
AmgenAMGN
$2.19B+57.4%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$1.08B+3.2%
Janux Therapeutics logo
Janux TherapeuticsJANX
-$12.34M+27.5%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$33.52M-190%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-$25.92M-142%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
-$88.9M-44.2%

Other financials

Income statement

See full
Revenue$4.5M-86.2%
Operating income-$77.9M-80.3%
Net income-$128.9M-166%
EPS (diluted)-$1.71-159%

Balance sheet

See full
Cash & equivalents$14.2M-64.3%
Total debt$175.2M-21.2%
Total equity$515.6M-19.4%
Total assets$736.8M-18.6%

Cash flow

See full
CapEx$610.0K-57.8%
Free cash flow-$68.2M-286%

Valuation

See full
Market cap$1.07B+76.3%
Enterprise value$1.23B+55.9%
P/S11×+6.2×

Profitability

See full
Operating margin-217.9%+425pp
Net margin-177.1%+16.5pp
FCF margin-194%+166pp

Returns & leverage

See full
Return on equity-29.8%-2.7pp
Debt / equity0.3×0.0×
Current ratio6.6×+0.7×

Where this comes from

Reported directly by Xencor in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Xencor’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xencor's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xencor's operating cash flow?
Xencor (XNCR) reported operating cash flow of -$67.63M in Q1 2026.
How has Xencor's operating cash flow changed year-over-year?
Xencor's operating cash flow decreased by 316.9% year-over-year, from -$16.22M to -$67.63M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.